1887

Abstract

India contributes heavily to the global burden of visceral leishmaniasis (VL, kala-azar) and human immunodeficiency virus (HIV)/AIDS. The prevalence of HIV seropositivity in VL patients at a tertiary care centre in northern India, as observed during a prospective study over a period of 2 years, is presented. Of the 104 cases of VL/post-kala-azar dermal leishmaniasis, six (5.7 %) were found to be HIV positive, compared to 11 (5.5 %) seropositive for HIV of 198 patients with fever due to other causes. Four of the six (67 %) VL/HIV co-infected patients had a chronic/relapsing course, not responding to antileishmanial treatment. A CD4 T-cell count of <200 mm was found in four of the five (80 %) co-infected patients in whom the test was done. Although the level of HIV/VL co-infection in the present study was lower than that of Mediterranean countries, there is a trend towards rising co-infection. The VL-endemic states of India have a huge population of migrant labourers, who work in high-HIV-prevalence states. The reported increase in the prevalence of HIV in the VL-endemic, populous states of India is a cause of grave concern, and co-infection may assume epidemic proportions in the coming decade if left unchecked.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46574-0
2006-07-01
2019-11-17
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/7/919.html?itemId=/content/journal/jmm/10.1099/jmm.0.46574-0&mimeType=html&fmt=ahah

References

  1. Alvar, J., Canavate, C., Gutierrez-Solar, B. Jimenez M., Laguna, F., Lopez-Velez, R., Molina, R. & Moreno, J. ( 1997; ). Leishmania and Human Immunodeficiency Virus coinfection: the first 10 years. Clin Microbiol Rev 10, 298–319.
    [Google Scholar]
  2. Bora, D. ( 1999; ). Epidemiology of visceral leishmaniasis in India. Natl Med J India 12, 62–68.
    [Google Scholar]
  3. Centres for Disease Control and Prevention ( 2001; ). Revised guidelines for HIV counseling, testing and referral. Morb Mortal Wkly Rep 50, RR19, 1–58.
    [Google Scholar]
  4. Lopez-Velez, R., Jose, A., Molina, P., Guerrero, A., Baquero, F. & Villarrubia, J. ( 1998; ). Clinicoepidemiologic characteristics, prognostic factors and survival analysis of patients coinfected with Human Immunodeficiency Virus and Leishmania in an area of Madrid, Spain. Am J Trop Med Hyg 58, 436–443.
    [Google Scholar]
  5. Pintado, V. & Lopez-Velez, R. ( 2001; ). HIV-associated visceral leishmaniasis. Clin Microbiol Infect 7, 291–300.[CrossRef]
    [Google Scholar]
  6. Pintado, V., Martin-Rabadan, P., Rivera, M., Moreno, S., Bouza, E. ( 2001; ). Visceral leishmaniasis in Human Immunodeficiency Virus (HIV)-infected and non HIV infected patients. Medicine 80, 54–73.[CrossRef]
    [Google Scholar]
  7. Sinha, P. K., Rabidas, V. N., Pandey, K., Verma, N., Gupta, A. K., Ranjan, A. & Das, B. ( 2003; ). Visceral leishmaniasis and HIV coinfection in Bihar, India. J Acq Immun Def Syndr 32, 115–116.[CrossRef]
    [Google Scholar]
  8. Thakur, C. P., Sinha, P. K., Singh, R. K., Hassan, S. M. & Narain, S. ( 2000; ). Miltefosine in a case of visceral leishmaniasis with HIV co-infection and rising incidence of this disease in India. Trans R Soc Trop Med Hyg 94, 696–697.[CrossRef]
    [Google Scholar]
  9. Thakur, C. P., Narayan, S. & Ranjan, A. ( 2003; ). Kala-azar (visceral leishmaniasis) and HIV coinfection in Bihar, India: is this combination increasing? J Acq Immun Def Syndr 32, 512–513.
    [Google Scholar]
  10. USAID ( 2003; ). HIV/AIDS country profile, India, March. http://www.usaid.gov/our_work/global_health/aids/countries/ane/India_05.pdf
  11. World Health Organization ( 1995; ). Report on the Consultative Meeting on Leishmania/HIV Co-infection. Report no. WHO/LEISH/ 95.35, pp. 1–14. Geneva: World Health Organization.
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46574-0
Loading
/content/journal/jmm/10.1099/jmm.0.46574-0
Loading

Data & Media loading...

Supplements

vol. , part 7, pp. 919–922

Supplementary Fig. S1. [PDF file](22 KB)



PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error